Embryonic stem cell research binds France, Israel

September 18, 2006 21:33


Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later Don't show it again

The French government has approved the establishment of a unique joint research center with the Technion-Israel Institute of Technology in Haifa that will focus on embryonic stem cells, which could lead to cures of numerous diseases. The signing ceremony was held Monday, with Prof. Christian Brechot, director of INSERM (Institute National de la Sante et de la Recherche Medicale) - France's national institute of health research - representing his country. The new center, which will initially pay for French researchers to spend time in Haifa and for sending an Israeli researcher to France.

Related Content

[illustrative photo]
September 24, 2011
Diabetes may significantly increase risk of dementia